Health Company Granted FDA Orphan Drug Status For Marburg Virus Prophylaxis
FDA Grants Orphan Drug Status to Soligenix's MarVax™: A Turning Point in Marburg Virus Prophylaxis.
Disclaimer: The content below is for informational purposes only and does not constitute medical advice.